Pentaglobin in CRE and PA Neutropenic Infections

Summary

To demonstrate that the early addition of Pentaglobin to the best available antimicrobial therapy is able to reduce mortality and improve survival in neutropenic febrile acute leukemia or allo- Hematopoietic stem cell transplantation (HSCT) patients colonized by carbapenem-resistant Enterobacteriaceae or by any Pseudomonas aeruginosa.

Timeline

Start

2019-12-06

Primary completion

2024-05-31

Completion

2025-05-31

Drugs

Indications